Ensacove
FDA Approves Ensacove for ALK-Positive Locally Advanced or Metastatic NSCLC
The FDA approved Ensacove for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or ...
DECEMBER 19, 2024

Load more